Our previous findings have suggested that PMP (when incorporated into CRC cells) can stimulate the expression and activity of the metalloproteases MMP-2 and MMP-9, which leads to a more invasive cell phenotype in vitro [7]. Here, MMP2 is linked to colorectal carcinoma.